SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-20-045827
Filing Date
2020-10-05
Accepted
2020-10-05 17:02:28
Documents
12
Period of Report
2020-09-30
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K acor-8k_20200930.htm   iXBRL 8-K 31473
  Complete submission text file 0001564590-20-045827.txt   156153

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA acor-20200930.xsd EX-101.SCH 5768
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE acor-20200930_lab.xml EX-101.LAB 18732
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE acor-20200930_pre.xml EX-101.PRE 11167
5 EXTRACTED XBRL INSTANCE DOCUMENT acor-8k_20200930_htm.xml XML 3419
Mailing Address 420 SAW MILL RIVER ROAD ARDSLEY NY 10502
Business Address 420 SAW MILL RIVER ROAD ARDSLEY NY 10502 914-347-4300
ACORDA THERAPEUTICS INC (Filer) CIK: 0001008848 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-31938 | Film No.: 201224331
SIC: 2836 Biological Products, (No Diagnostic Substances)